BUSINESSCNBC-TV18 Markets ยท 0 seconds agoLive
JPMorgan upgrades Dr. Reddy's after Q2 results but still remains on the sidelines; here's why - CNBC TV18
Reported by CNBC-TV18 Markets, not nibnow. We are not the publisher; this is a short summary that may be AI-assisted and can contain mistakes. Read the original for the full story. Publisher or rights holder? Request removal or a correction.
No additional analysis available for this story yet.
WHAT HAPPENED
The planned resumption of commercial semaglutide supplies in November 2026 remains on track, HSBC said, while citing that execution will be crucial for the company to gain market share. It also identified the semaglutide relaunch and US approval for abatacept as key catalysts for the stock.
Text size
READ IN YOUR LENS
UPSCMarketsFounder